GWAS |
- Amyotrophic lateral sclerosis ( 19451621)
- Atrial fibrillation ( 30061737 29892015)
- Breast cancer ( 29059683)
- Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) ( 31374203)
- Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes ( 29221444)
- Cortical amyloid beta load ( 29860282)
- Gambling ( 22780124)
- General cognitive ability ( 29844566)
- Generalized epilepsy ( 30531953)
- Granulocyte count ( 27863252)
- High light scatter reticulocyte count ( 27863252)
- High light scatter reticulocyte percentage of red cells ( 27863252)
- Household income (MTAG) ( 31844048)
- Major depressive disorder ( 23377640)
- Metabolite levels ( 23823483)
- Multiple sclerosis ( 31604244)
- Myeloid white cell count ( 27863252)
- Neutrophil count ( 29403010 27863252)
- Reticulocyte count ( 27863252)
- Reticulocyte fraction of red cells ( 27863252)
- Subcutaneous adipose tissue attenuation (Hounsfield unit scale) ( 27918534)
- Sum basophil neutrophil counts ( 27863252)
- Sum neutrophil eosinophil counts ( 27863252)
- Systemic lupus erythematosus ( 27399966 28714469)
- Total body bone mineral density ( 30172743)
- Visceral adipose tissue attenuation (Hounslow unit scale) ( 27918534)
- White blood cell count ( 29403010 27863252)
|
- Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) level) ( 27702941)
- Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio) ( 27702941)
- Caffeine metabolism (plasma 3,7-dimethylxanthine (theobromine) level) ( 27702941)
- Kawasaki disease ( 22446962)
- Lung adenocarcinoma ( 28604730)
- Lung cancer ( 28604730)
|